Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432380
Status:
COMPLETED
Last Update Posted:
2020-01-02
First Post:
2007-02-06
Brief Title:
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals HRV Liquid Vaccine in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Immunogenicity and Safety of Two Doses of GlaxoSmithKline GSK Biologicals Oral Live Attenuated Human Rotavirus HRV Liquid Vaccine GSK 357941A in Healthy Infants
Status:
COMPLETED
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will provide data on the immune response and safety of GSK Biologicals HRV liquid vaccine when given along with the routine infant immunizations in Philippines
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2015-001544-11 | EUDRACT_NUMBER | None | None |